These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26340999)

  • 1. Personalized Devices Predict Cancer Drug Sensitivity In Vivo.
    Balakrishnan VS
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26340999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methods for optimizing cytostatic drug therapy].
    Lipp HP
    Med Monatsschr Pharm; 1995 Oct; 18(10):282-91. PubMed ID: 7476654
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 4. Precision pharmacology: Mass spectrometry imaging and pharmacokinetic drug resistance.
    Jove M; Spencer J; Clench M; Loadman PM; Twelves C
    Crit Rev Oncol Hematol; 2019 Sep; 141():153-162. PubMed ID: 31302407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale delivery systems for multiple drug combinations in cancer.
    Cao Y; Wang B; Lou D; Wang Y; Hao S; Zhang L
    Future Oncol; 2011 Nov; 7(11):1347-57. PubMed ID: 22044207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Safe Infusion Devices for Antineoplastic Administration.
    Lalande L; Galy G; Dussossoy E; Noyel JE; Pivot C
    J Infus Nurs; 2015; 38 Suppl 6():S29-35. PubMed ID: 26536408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in Greifswald.
    Ritter C; Sehrt D; Jaehde U
    Int J Clin Pharmacol Ther; 2012 Jan; 50(1):53-4. PubMed ID: 22192647
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal models for personalized treatment options.
    Fichtner I; Klinghammer K; Behrens D; Flechsig S; Rolff J; Becker M; Wulf-Goldenberg A; Stecklum M; Rivera M; Brzezicha B; Jandrig B; Hoffmann J
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):698-700. PubMed ID: 28696202
    [No Abstract]   [Full Text] [Related]  

  • 9. Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy.
    Astolfi M; Péant B; Lateef MA; Rousset N; Kendall-Dupont J; Carmona E; Monet F; Saad F; Provencher D; Mes-Masson AM; Gervais T
    Lab Chip; 2016 Jan; 16(2):312-25. PubMed ID: 26659477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Clinical Pharmacology in Oncology Dose Selection: Advances and Opportunities in Personalized Medicine.
    Shord SS
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S99-S104. PubMed ID: 28921640
    [No Abstract]   [Full Text] [Related]  

  • 11. Personalized drug administration for cancer treatment using Model Reference Adaptive Control.
    Babaei N; Salamci MU
    J Theor Biol; 2015 Apr; 371():24-44. PubMed ID: 25665717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Use of archived specimens in evaluation of prognostic and predictive biomarkers.
    Ahern TP; Hankinson SE
    J Natl Cancer Inst; 2011 Oct; 103(20):1558-9; author reply 1559-60. PubMed ID: 21917608
    [No Abstract]   [Full Text] [Related]  

  • 13. Precision Tumor Medicine and Drug Targets.
    Liu W; Wang X; Zhu H; Duan Y
    Curr Top Med Chem; 2019; 19(17):1488-1489. PubMed ID: 31592750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Developments in chemotherapy; cytostatic agents with an increased specificity and other forms of administering cytotoxic antineoplastic agents].
    Eskens FA; de Jonge MJ; Verweij J
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2208-13. PubMed ID: 11757242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine and economic evaluation in oncology: all theory and no practice?
    Garattini L; Curto A; Freemantle N
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):733-8. PubMed ID: 26289733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format.
    Diken M; Kreiter S; Kloke B; Sahin U
    Prog Tumor Res; 2015; 42():44-54. PubMed ID: 26383626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment.
    Oliva N; Unterman S; Zhang Y; Conde J; Song HS; Artzi N
    Adv Healthc Mater; 2015 Aug; 4(11):1584-99. PubMed ID: 25963621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nanomedicine : Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy].
    Alexiou C; Tietze R; Schreiber E; Lyer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):839-45. PubMed ID: 20700784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real Personalized Medicine.
    Armitage JO; Wood WC; Longo DL
    J Natl Compr Canc Netw; 2016 Feb; 14(2):233-6. PubMed ID: 26850491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.